AnalystsAlex NowarkAlex Nowark's Stock Forecasts
AnalystsAlex Nowark
Analyst Ranking
Top 8%
#434 out of 5502 analysts
Average Return
+214.63%
Win Rate
50%8 out of 16
Risk vs Reward
Poor
Good
Alex Nowark's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Exact Sciences CorpEXAS | +3,230.52% | $56.00 | $1,865.09 | 2025-09-11 - 2026-03-24 | Buy |
Guardant Health IncGH | +152.15% | $18.10 | $45.64 | 2024-04-24 - 2025-04-23 | Buy |
Exact Sciences CorpEXAS | +78.88% | $47.59 | $85.13 | 2022-08-03 - 2023-08-02 | Buy |
Neogenomics IncNEO | +75.00% | $29.48 | $51.59 | 2020-03-02 - 2021-03-02 | Buy |
Guardant Health IncGH | +66.47% | $30.27 | $50.39 | 2024-08-08 - 2025-08-07 | Buy |
Alex Nowark Analyst Color
Get additional color on Alex Nowark's coverage of popular stocks
Alex Nowark's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Xtant Medical Holdings IncXTNT | 1 | Strong Buy | $1.00 | +144.50% | Initiates Coverage On | a day ago |
Insight Molecular Diagnostics IncIMDX | 1 | Strong Buy | $8.00 | +99.50% | Initiates Coverage On | 10 days ago |
Envoy Medical IncCOCH | 1 | Strong Buy | $2.00 | +190.28% | Initiates Coverage On | a month ago |
Adagio Medical Holdings IncADGM | 1 | Strong Buy | $3.00 | +466.04% | Initiates Coverage On | 3 months ago |
Microbot Medical IncMBOT | 1 | Strong Buy | $4.00 | +173.97% | Initiates Coverage On | 3 months ago |
Ss Innovations International IncSSII | 1 | Strong Buy | $7.00 | +105.88% | Initiates Coverage On | 3 months ago |
Exact Sciences CorpEXAS | 4 | Buy | $85.00 | -95.44% | Maintains | a year ago |
Guardant Health IncGH | 3 | Buy | $37.00 | N/A | Maintains | 2 years ago |
Neogenomics IncNEO | 2 | Buy | $26.00 | N/A | Assumes | 2 years ago |
Smiledirectclub IncSDCCQ | 2 | Hold | N/A | N/A | Upgrades | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.